Latest National Holdings (NHLD) Headlines Neptune

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest National Holdings (NHLD) Headlines

Neptune Announces Closing of the Over-Allotment Option Associated with its Recently Completed Public Offering of Common Shares
PR Newswire - Thu Mar 06, 10:53AM CST
Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.NTB), announced today that the syndicate of underwriters led by of Euro Pacific Canada Inc. and Roth Capital Partners, as Joint Book-Running Managers, and National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc. (NHLD) as Lead Manager, have exercised in full the over-allotment option to purchase an additional 1,500,000 common shares of Neptune at a price of US$2.50 per common share in connection with Neptune's previously announced public offering, completed on March 5, 2014. As a result of the exercise of the over-allotment option, Neptune received additional gross proceeds of US$3.75 million for total gross proceeds of US$28.75 million.

Iroquois Capital Delivers Letter to National Holdings Corporation
PR Newswire - Thu Mar 06, 7:12AM CST
Iroquois Capital Management, LLC (together with its affiliates, "Iroquois"), one of the largest shareholders of National Holdings Corporation ("OTC BB: NHLD" or the "Company") with beneficial ownership of approximately 5.9% of the outstanding common stock of the Company, today announced that it has delivered a letter to the Company's Chief Executive Officer, Mark Klein, and the members of the Company's Board of Directors.

Neptune Announces Closing of US$25.0 Million Underwritten Offering of Common Shares
CNW Group - Wed Mar 05, 8:11AM CST
Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.NTB), a biotechnology company engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids, announced today the closing of its previously announced public offering of 10,000,000 common shares at US$2.50 per common share for gross proceeds of US$25.0 million. Euro Pacific Canada Inc. and Roth Capital Partners, LLC acted as Joint Book-Running Managers for the offering and National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc. (NHLD), acted as Lead Manager.

National Holdings Posts Fiscal 1st Quarter 2014 Results
Close-Up Media - Thu Feb 20, 11:32PM CST
National Holdings Corp., a full-service investment banking and asset management firm, announced financial results for the Company's fiscal first quarter ended December 31, 2013.

National Holdings Corporation Reports Fiscal First Quarter 2014 Results
Business Wire - Tue Feb 18, 7:00AM CST
National Holdings Corporation (OTCBB:NHLD) ("National Holdings" or the "Company"), a full-service investment banking and asset management firm, today announced financial results for the Company's fiscal first quarter ended December 31, 2013.

ZOFT Produces Custom Range of Sweet Candy Gifts for Sweethearts This Valentine's Day
M2 - Fri Feb 14, 3:12AM CST
ZOFT create Gum, Mints, Candy and Confections for suppliers around the world, and is offering heart-shaped special orders to help brands cash in when love is in the air.

National Holdings Corporation to Report Fiscal First Quarter 2014 Financial Results
Business Wire - Thu Feb 13, 7:00AM CST
National Holdings Corporation (OTC BB:NHLD) ("National Holdings" or the "Company") today announced that it will host a teleconference to discuss the Company's fiscal first quarter 2014 financial results at 10:00 a.m. ET on Tuesday, February 18, 2014. National Holdings will release its 2014 fiscal first quarter financial results prior to the market open on February 18, 2014.

Peregrine Pharmaceuticals Prices Offering of Its Series E Preferred Stock
Marketwire - Tue Feb 11, 7:03AM CST
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) (the "Company"), announced today that it has priced an underwritten public offering of 700,000 shares of its 10.50% Series E Convertible Preferred Stock (the "Series E Preferred Stock") at a public offering price of $25.00 per share. Holders of Series E Preferred Stock may convert their shares, in whole or in part, into shares of the Company's common stock at a conversion price of $3.00 per share. Gross proceeds to the Company are expected to be approximately $17.5 million ($20.1 million if the option described below is exercised in full) before deducting the underwriting discount and other estimated offering expenses payable by the Company. The offering is expected to close on or about February 19, 2014, subject to the satisfaction of customary closing conditions. The Company has also granted the underwriters an option to purchase up to an aggregate of 105,000 additional shares of its Series E Preferred Stock offered in the public offering, exercisable for 30 days. The Company intends to use the net proceeds from the offering for general corporate purposes. The Company has filed an application to list the shares of Series E Preferred Stock on the NASDAQ Capital Market under the symbol "PPHMP". If approved by NASDAQ, trading of the Series E Preferred Stock on the NASDAQ is expected to begin within 30 days after the date of initial issuance of the Series E Preferred Stock. MLV & Co. LLC is acting as sole book-runner. Maxim Group LLC and National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc. (OTCBB: NHLD), are acting as lead managers for the offering and Empire Asset Management and I-Bankers Securities, Inc. are acting as co-managers for the offering. Roth Capital Partners, LLC and Piper Jaffray & Co. served as financial advisors to Peregrine.

Torchlight Energy Completes Equity Financing
Marketwire - Mon Feb 03, 7:01AM CST
Torchlight Energy Resources, Inc. (NASDAQ: TRCH) today announced that it has raised $5.6 million in a private placement offering of stock and warrants completed on January 31, 2014. National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc.(OTCBB: NHLD), was the sole placement agent. Proceeds from the offering will be used to fund its previously disclosed drilling programs.

Orchid Island Capital Announces Closing of Sale of Shares Pursuant to Full Exercise of Underwriters' Overallotment Option
GlobeNewswire - Wed Jan 29, 11:33AM CST
Orchid Island Capital, Inc. (the "Company") (NYSE MKT:ORC) announced today the closing of the sale of 270,000 shares of its common stock for net proceeds of $3,157,650 pursuant to the full exercise of the underwriters' overallotment option granted in connection with the Company's public offering that closed on January 23, 2014. All of the shares in the public offering, including the shares sold pursuant to the overallotment option, were offered by the Company. The shares are listed in the NYSE MKT under the symbol "ORC."

Tonix Pharmaceuticals Announces Closing of $43.5 Million Public Offering of Common Stock
GlobeNewswire - Wed Jan 29, 10:15AM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the closing of its previously announced underwritten public offering of 2,898,550 shares of its common stock. The shares were sold at the public offering price of $15.00 per share, bringing the aggregate gross proceeds from the offering to approximately $43.5 million, before deducting underwriting discounts and commissions and other offering expenses.

First flight from Abu Dhabi Pre-clearance facility marks sad day for U.S. airline industry
PR Newswire - Fri Jan 24, 5:12PM CST
Today marks a sad day for the U.S. airline industry, as the Southwest Airlines Pilots' Association (SWAPA) learned that the first flight from Abu Dhabi to the United States was operated utilizing the Customs and Border Patrol's Pre-Clearance facility located at the Abu Dhabi airport.

Tonix Pharmaceuticals Prices Underwritten Public Offering Raising $43.5 Million
GlobeNewswire - Fri Jan 24, 7:20AM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the pricing of an underwritten public offering of 2,898,550 shares of its common stock at a price of $15.00 per share. The company has also granted to the underwriters a 45-day option to acquire an additional 434,782 shares to cover overallotments in connection with the offering. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $40.7 million, assuming no exercise of the overallotment option. The offering is expected to close on January 29, 2014, subject to customary closing conditions.

Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock
GlobeNewswire - Thu Jan 23, 3:02PM CST
Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, today announced that it intends to offer shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Orchid Island Capital Closes Public Offering of Common Stock
GlobeNewswire - Thu Jan 23, 10:42AM CST
Orchid Island Capital, Inc. (the "Company") (NYSE MKT:ORC) announced that it closed its previously announced public offering of 1,800,000 shares of common stock at a public offering price of $12.50 per share earlier today. All of the shares in the public offering were offered by the Company. The shares are listed in the NYSE MKT under the symbol "ORC."

Orchid Island Capital Prices Public Offering of Common Stock
GlobeNewswire - Thu Jan 16, 4:59PM CST
Orchid Island Capital, Inc. (the "Company") (NYSE MKT:ORC) announced today the pricing of its public offering of 1,800,000 shares of common stock at $12.50 per share. The offering is expected to close on January 23, 2014. The Company has granted the underwriters a 30-day option to purchase up to an additional 270,000 shares of common stock on the same terms and conditions to cover over-allotments, if any. All of the shares in the public offering are being offered by the Company.

Full Circle Capital Corporation Prices Public Offering of Common Stock
Business Wire - Tue Jan 14, 8:12AM CST
Full Circle Capital Corporation (NASDAQ:FULL) ("Full Circle Capital"), today announced that it priced a public offering of 1,650,000 shares of its common stock at a public offering price of $7.13 per share for total gross proceeds of $11,764,500. Full Circle has also granted the underwriters a 30-day option to purchase up to 242,300 additional shares of common stock on the same terms and conditions to cover over-allotments, if any.

National Holdings Corporation to Reschedule Conference Call Regarding Fiscal 2013 Results Previously Announced on December 27, 2013
Business Wire - Thu Jan 09, 6:29AM CST
National Holdings Corporation (OTC BB: NHLD) ("National Holdings" or the "Company") today announced that it has postponed its fiscal year 2013 earnings update call originally scheduled for Thursday, January 9, 2014, at 9:00 AM ET.

National Holdings Corp. (NHLD) Stock Research Links

NHLD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 3

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
Atli Launches: AI-Powered eSIM Revolutionizes Travel

Updated Category News Views 5

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Continue Reading
Moore Law Investigates Aardvark Therapeutics' Risks

Updated Category News Views 2

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 2

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Albertsons Welcomes Once Upon a Coconut Nationwide

Updated Category News Views 4

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Continue Reading
Diaper Affordability: A Hidden Crisis, Taxpayer Burden

Updated Category News Views 6

A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 3

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Updated Category News Views 7

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Continue Reading
Mobile Iron IV Expansions: Targeting Texas Health Needs

Updated Category News Views 13

Out in Texas, folks facing iron deficiency have a new game-changer coming their way. Drip Gym, the same outfit making waves out in Queens and Long Island, is taking their mobile iron IV therapy clinic straight to Texan doorsteps. No more trotting off to a clinic for iron infusions with this crew rolling into Houston, Dallas, Austin, and San Antonio. What's the Big Deal?...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading

Top 5 Most Recently Viewed Articles

Fiverr Reports Record Revenue and EBITDA for Q3 2025

Updated Category News Views 316

Fiverr Delivers Impressive Third Quarter Results Fiverr International Ltd. (NYSE: FVRR) has unveiled its financial results for the third quarter of 2025, showcasing significant growth and robust performance metrics. The company has continued to embrace AI and upmarket strategies, which proved beneficial for its revenue generation and overall financial health. Strong...

Continue Reading
Manhattan Bridge Capital, Inc. Announces New Dividend Payout

Updated Category News Views 117

Manhattan Bridge Capital, Inc. Confirms Significant Quarterly Dividend Recently, Manhattan Bridge Capital, Inc. (NASDAQ: LOAN) made an exciting announcement regarding its financial commitment to its shareholders. The board of directors has approved a quarterly dividend of $0.115 per share. This decision reflects the company's continuing efforts to enhance shareholder...

Continue Reading
Exciting Progress for Praxis Precision Medicines in Tremor Treatment

Updated Category News Views 211

Promising Developments for Praxis Precision Medicines BOSTON, Dec. 04, 2025 – Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a pioneering biopharmaceutical company, has achieved a significant milestone by successfully completing a pre-NDA (New Drug Application) meeting with the FDA. This meeting included valuable feedback from the agency and a face-to-face discussion,...

Continue Reading
Persante Health Care Addresses Recent Data Security Incident

Updated Category News Views 418

Persante Health Care Addresses Recent Data Security Incident Persante Health Care has notified individuals about a serious data security incident that may have affected personal and/or protected health information. As a national provider of management services for sleep and balance centers, Persante values the privacy of its clients' information immensely. This situation...

Continue Reading
Baltimore's Vision for Housing: A New Chapter in Development

Updated Category News Views 278

Baltimore's Ambitious Housing Redevelopment Plan In a bold move towards addressing a pressing housing shortage, Baltimore is embarking on an expansive housing redevelopment initiative. This visionary plan is set to revitalize neighborhoods, eliminating countless vacant properties and restoring community appeal across the city. The scale and scope of this project make it a...

Continue Reading